Why Does the AstraZeneca COVID-19 Vaccine’s Efficacy Vary So Much? Here’s What We Know – TIME Related: Why Oxford’s positive COVID vaccine results are puzzling scientists – Nature
The post Why does the AstraZeneca-Oxford COVID-19 vaccine’s efficacy vary so much? Here’s what we know appeared first on Links Medicus.
Why the AstraZeneca-Oxford Covid-19 vaccine is different – Vox
The post Why the AstraZeneca-Oxford Covid-19 vaccine is different. It does not require extremely cold temperatures for storage, and the price will be “a fraction” of the expense of the other vaccine candidates appeared first on Links Medicus.
Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19 – JAMA Commentary on Twitter Arterial and venous thrombosis are common in #COVID19, especially in critically ill patients. Thromboprophylaxis should be considered for all hospitalized patients with COVID-19 in the absence of contraindications https://t.co/sjqL7MqGLX — JAMA (@JAMA_current) November 23, 2020
The post Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19 appeared first on Links Medicus.
SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis – The Lancet Microbe Commentaries: COVID-19 most contagious in first 5 days of illness, study finds – CIDRAP AND Infectiousness peaks early in COVID-19 patients, emphasising the need to rapidly isolate cases – The Lancet AND Covid-19 […]
The post Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset appeared first on Links Medicus.
Covid-19: Oxford University vaccine shows 70% protection – BBC News release: Oxford University breakthrough on global COVID-19 vaccine Commentary on Twitter Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one […]
The post Covid-19: Oxford University vaccine shows 70% protection appeared first on Links Medicus.
Interventions for Breathlessness in Patients With Advanced Cancer – Agency for Healthcare Research and Quality Full report: Interventions for breathlessness in patients with advanced cancer Evidence Summary: Interventions for breathlessness in patients with advanced cancer
The post Systematic review: Interventions for breathlessness in patients with advanced cancer appeared first on Links Medicus.
A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications – JAMA Commentary on Twitter The #COVID19 response focuses on acute illness, but accumulating evidence shows morbidity beyond acute infection, with at least 2 other periods of illness: a rare postacute hyperinflammatory […]
The post A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications appeared first on Links Medicus.
|
||||||||||||||||||||||
How to ventilate obstructive and asthmatic patients – Intensive Care Medicine Commentary on Twitter Ventilation in #COPD & asthma➡️ respiratory mechanics/gas exchange➡️ heart–lung interactions➡️ HFNO & NIV➡️ managing invasive MV from intubation to (early) weaning limiting hyperinflation➡️ long‑term outcome & role of tracheostomy➡️ future strategieshttps://t.co/zBBlwo7EEI pic.twitter.com/4WPeYJZrh4 — Intens Care Med (@yourICM) November 9, 2020 […]
The post Review: How to ventilate obstructive and asthmatic patients appeared first on Links Medicus.
Routine laboratory testing to determine if a patient has COVID‐19 – Cochrane Library Summary: Routine laboratory testing to determine if a patient has COVID‐19 – Cochrane Library
The post Systematic review: Routine laboratory tests are not useful for accurately ruling in or ruling out COVID-19 on their own appeared first on Links Medicus.